Basic Mechanism in Lysosomal Disorders: Phenotypic Diversity and Cell Biology
Learn the role of protein activators in lysosomal disorders and the role of inflammatory pathways in sphingolipid disorders.
Related Articles
Certain Breast Cancer Subtypes May Derive a Greater Benefit With Ribociclib Combo vs Chemo
Patients with luminal B and HER2E breast cancer subtypes may have a greater PFS benefit with ribociclib plus endocrine therapy vs combination chemotherapy.
FDA Grants Fast Track Designation to IMM-1-104 in NRAS+ Advanced Melanoma
The FDA has granted fast track designation to IMM-1-104 for the treatment of advanced melanoma.
Assessment of the Addition of Oxaliplatin to Fluoropyrimidine-Based Adjuvant Chemotherapy in Patients With High-Risk Stage II Colon Cancer: An ACCENT Pooled Analysis | Journal of Clinical Oncology
PURPOSE The adjuvant treatment for stage III colon cancer (CC) is chemotherapy combining fluoropyrimidine (FP) and oxaliplatin (OX). FP regimen plus OX (FPOX) may benefit…
Tisagenlecleucel Maintains Long-Term Efficacy in R/R Follicular Lymphoma
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
The Cancer Letter turns 50 Documenting half a century of cancer progress – The Cancer Letter
On Dec. 21, 1973, Jerry D. Boyd ran the first printing of a little newsletter that would become The Cancer Letter. Today, 50 years later,…
Featured Articles Archive – Society of Surgical Oncology
2024 Featured Articles May 23 – Practice Patterns and Outcomes Among Surgical Oncology Fellowship Graduates Performing Complex Cancer Surgery in the United States Across Different…
Improved Uptake and Adherence to Risk-Reducing Medication with the Use of Low-Dose Tamoxifen in Patients at High Risk for Breast Cancer
tam has been used extensively for breast cancer prevention in high-risk women. Historical uptake has been low because of concern for side effects and poor…
